Effect of Dexmedetomidine on Parturient Undergoing Elective Cesarean Section.

PHASE4CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

December 2, 2019

Study Completion Date

December 2, 2019

Conditions
Cesarean Section
Interventions
DRUG

dexmedetomidine group

After the fetus was delivered, low-dose dexmedetomidine intraoperative infusion, postoperative low-dose dexmedetomidine patient-controlled intravenous analgesia pump(the background infusion is 2 ml/h, the bolus dose is 0.5 ml, the lock time is 15 min).

DRUG

control group

After the fetus was delivered, saline intraoperative infusion, postoperative patient-controlled intravenous analgesia pump(the background infusion is 2 ml/h, the bolus dose is 0.5 ml, the lock time is 15 min) without dexmedetomidine.

Trial Locations (1)

221000

The Affiliated Hospital of Xuzhou Medical University, Xuzhou

All Listed Sponsors
lead

The Affiliated Hospital of Xuzhou Medical University

OTHER

NCT03805945 - Effect of Dexmedetomidine on Parturient Undergoing Elective Cesarean Section. | Biotech Hunter | Biotech Hunter